Navigation Links
US Pharmacopeia releases new edition of the Food Chemicals Codex
Date:3/4/2008

Rockville, Md., March 4, 2008 The U.S. Pharmacopeia (USP) today announced the release of the latest edition of the Food Chemicals Codex (FCC), a compendium that sets standards for the identity, quality and purity of ingredients found in foods consumed by the public every day, including colorings, flavorings, nutrients, preservatives and processing aids.

The new edition is the sixth publication of the compendium since 1966, and the first under USPs direction, having previously been published by the Institute of Medicine. The compendium is used by manufacturers of food, food chemicals and food ingredients to ensure that their products meet identity, purity and quality standards. As a private, science-based, non-governmental organization that sets the standards that prescription and over-the-counter medications sold in the United States must meet by law via the United States PharmacopeiaNational Formulary (USPNF) compendia, USP is well qualified to set similar standards for food ingredients.

With the increasing globalization of the food supply, the availability of pure and safe foods is more important than ever, said Darrell Abernethy, M.D., Ph.D., chief science officer for USP. This latest edition of the Food Chemicals Codex will help assure that food ingredients are meeting high standards of quality for public consumption, just as USP has done with pharmaceutical products for close to 200 years.

The new edition contains more than 1,000 monograph standards and tests to assure the identity, quality and purity of food ingredients. A new edition will be published every two years, with an annual supplement between editions. The FCC will be revised and updated via an open, transparent, participatory and scientific process that includes experts from industry as well as scientific, technical, governmental and trade organizations. All interested parties are encouraged to submit proposed revisions and comments through the online FCC Fo
'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pharmacopeia Announces Senior Additions to Management Team
2. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
3. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
4. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
5. U.S. Pharmacopeia 8th Annual MEDMARX(R) Report Indicates Look-Alike/Sound-Alike Drugs Lead to Thousands of Medication Errors Nationwide
6. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
7. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
8. Pharmacopeia to Present at The Roth 20th Annual OC Growth Stock Conference
9. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
10. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
11. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...firm Replikins Ltd. today issued its latest bioche... shows that the lethality of the virus has dropped...s current outbreak in the spring of 2009 to restin... The H1N1 infectivity count, however, remains incr...ovember 27, 2009 -- Biotech firm Replikins Ltd., w...
(Date:11/27/2009)...7/PRNewswire-FirstCall/--ShamirOpticalIndustryLtd....vativeproductsandtechnologytotheophthalmiclensmark...dadividenddistributioninanaggregateamountofUS$10mi...er25,2009representativerateofexchange),orapproxima...25,2009representativerateofexchange)perordinarysha...
(Date:11/27/2009)...ealth™ announced today that Spectrum Health ...d Enterprise orthopedic templating solution and it... (PRWEB) November 27, 2009 -- Voyant...h (Grand Rapids, Michigan) has licensed its Trauma...its TraumaCad Extend workflow solution, to allow i...
(Date:11/26/2009)...wswire/--ThediabetespopulationintheUnitedStateswil...ndingonthediseaseisprojectedtohit$336billion,upfro...ecemberissueof DiabetesCare .TheNational ChangingD...commissionedtheanalysisbyateamfromtheUniversityofC...ericanslivingwithdiabeteswillrisefrom23.7millionin...
(Date:11/26/2009)...letters from the North Pole, Textsanta.net lets pa...Santa , North Pole, AK (P...ciencies at the North Pole Santa Claus has added S...he globe informed of his Christmas progress at the...epartment have identified a large and growing perc...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...ormone replacement therapy (HRT) should not be pre...opause to help prevent chronic conditions such as ... view that HRT is a safe short term treatment for ... postmenopausal women taking HRT had more heart at...
... the UK could prevent up to 3200 deaths from heart...n the Journal of Epidemiology and Community Health... is already applied to confectionery, ice cream, s...te the likely impact of price rises on demand of a...
...University study published in the July issue of th...s seldom require screening for substance abuse an... improve detection. This may be a missed ...nstance Horgan, director of the Institute for Beha...
...lobin levels to help dialysis patients One... anemia. In order to live a better quality life, d...ate hemoglobin level. Thus anemia correction is a ...ow is the drug called erythropoiesis-stimulating a...
...ow and middle-income countries can turn out econom...clusion was reached by A UCSF-led team of researc...underway in countries like India, South Africa, Ug...th the recent report from the Global HIV Preventio...
...ts reaction to a particular variety of sugar prese...ording to Biology textbooks neutrophils are regard...rm an integral part of blood. They are the policem...uder that invades the body. A new study shows that...
Other Medicine News:Health News:Study Confirms No HRT Benefit for Older Women 2Health News:Study Confirms No HRT Benefit for Older Women 3Health News:Fat Tax Could Avoid Considerable Amount of Heart Attack and Stroke Deaths Annually 2Health News:Screening for Behavioral Health 2Health News:Analysis of Hemoglobin Level Control in Dialysis Patients 2Health News:Analysis of Hemoglobin Level Control in Dialysis Patients 3Health News:HIV Prevention Programs on a Massive Scale Turn Out Economical 2Health News:WBC Selective About Sugar 2
(Date:11/25/2009)...25/PRNewswire/--RegadoBiosciences,aprivatelyheldco...withactivecontrolagents,announcedthatDavidMazzo,Ph...y21stAnnualHealthCareConferenceattheNewYorkPalaceH...nat1:10pm(EST)onTuesday,December1andwillincludeano...developmentprogram,theanticoagulantsystem,REG1.The...
(Date:11/25/2009)...5/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ...ebloodanalysissystems,announcedtodaythatClintSever...the21stAnnualPiperJaffrayHealthCareConferenceonWed...lbeheldattheNewYorkPalaceHotelinNewYorkCity. ,,...dmarketsportablebloodanalysissystemsforuseinanyvet...
(Date:11/25/2009).../PRNewswire/--CempraPharmaceuticalsInc.todayannoun...tiveofficer,willpresentatthePiperJaffray21stAnnual...tTheNewYorkPalaceHotelinNewYorkCity.Dr.Fernandeswi...ticclinicalprogramsforthetreatmentofdrug-resistant...uticals ,, Foundedin2006,CempraPharmaceuticals...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 1AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 3AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 4Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 1Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 2Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 3Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 1Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 2Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 3Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 4
... Dec. 9 Portola,Pharmaceuticals, a biopharmaceuti...de significant advances in cardiovascular disease,...that it has initiated patient enrollment in,INNOVA...28, the Company,s,novel P2Y12 ADP receptor antagon...s coronary intervention (PCI). , "With the i...
...nnium: The Takeda Oncology Company today reported ...ients from the large, international Phase III VIST...for patients with previously untreated multiple my...P). The VELCADE combination demonstrated consisten...ose with poor prognostic characteristics, such as ...
Other Medicine Technology:Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention 2Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
Anorectal Water Perfused Catheters
AnorectalSolid State Manometry Catheters
Multi-Use Adult Anorectal Water Perfused Catheters
Multi-Use Adult Esophageal Water Perfused Catheters
Medicine Products: